Specify a stock or a cryptocurrency in the search bar to get a summary
RLS Global AB (publ)
RLSRLS Global AB (publ), a medical technology company, develops and sells products for minimally invasive treatment in Sweden. Its products include ChloraSolv that is used for the treatment of chronic diabetic foot and leg ulcers for diabetic patients; and CariSolv, a gel used for removing caries. RLS Global AB (publ), was founded in 1996 and is based in Mölndal, Sweden. Address: Neongatan 5, Mölndal, Sweden, 431 53
Analytics
WallStreet Target Price
59.14 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures RLS
Dividend Analytics RLS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History RLS
Stock Valuation RLS
Financials RLS
Results | 2019 | Dynamics |